Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Berg, A. O.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REPLY

Screening for Prostate Cancer

right arrow Alfred O. Berg, MD, MPH

16 September 2003 | Volume 139 Issue 6 | Page 532


IN RESPONSE:

Drs. Smith and Robertson share the common view that all prostate cancer, if left alone, will grow, spread, and kill. This is fortunately not the case. Some cancerous prostate tumors clearly grow and spread with devastating consequences, as both correspondents remind us, but most do not. The core of the difficulty is that clinicians cannot tell which is which at the time of diagnosis following a positive result on a screening test.

Autopsy studies show that approximately 30% of men at age 50 years, 50% of men at age 70 years, and almost all men by age 100 years have histologic cancer in the prostate. Thus, the tendency to recommend treatment for all men with a diagnosis of prostate cancer undoubtedly appropriately treats some but also harms those whose cancer could safely have been left alone. Even men who choose watchful waiting live with the awareness of having prostate cancer. In either case—treatment or watchful waiting—some men may suffer more harm than good from screening.

As with all screening tests, the USPSTF believes that individuals who are unwilling to undergo further diagnostic testing, treatment, and follow-up for positive test results should think carefully before having a prostate cancer screening test. Reasonable men may decide not to pursue such knowledge. Forcing men to learn they have prostate cancer through routine screening is, we believe, more paternalistic than offering them the opportunity to participate in an informed choice about whether to be screened in the first place.

Men now face a very difficult decision in balancing the potential benefit of screening, which may be enormous—avoidance of death from prostate cancer—against the potential harms, which are also significant and well documented. The USPSTF believes that the decision should be firmly in the hands of the patient. Unfortunately, we found the scientific evidence insufficient to recommend for or against routine screening. We hope that trials of screening now under way will provide better-quality evidence on which to base the decision.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info

From U.S. Preventive Services Task Force; Rockville, MD 20852.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.


Related articles in Annals:

Clinical Guidelines
Screening for Prostate Cancer: Recommendation and Rationale
U.S. Preventive Services Task Force*
Annals 2002 137: 915-916. [ABSTRACT][SUMMARY][Full Text]  

Clinical Guidelines
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
Russell Harris AND Kathleen N. Lohr
Annals 2002 137: 917-929. [ABSTRACT][SUMMARY][Full Text]  

Letters
Screening for Prostate Cancer
Robert L. Smith
Annals 2003 139: 531. [Full Text]  

Letters
Screening for Prostate Cancer
H. Thomas Robertson
Annals 2003 139: 531-532. [Full Text]  




box Article
 arrow  Table of Contents                
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Berg, A. O.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online